• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青年发病型糖尿病与纤维蛋白相关血栓形成风险。

Maturity onset diabetes of the young and fibrin-related thrombosis risk.

机构信息

Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire, UK.

Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.

出版信息

Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120963048. doi: 10.1177/1479164120963048.

DOI:10.1177/1479164120963048
PMID:33334146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7919224/
Abstract

BACKGROUND

Fibrin network characteristics determine predisposition to cardiovascular disease (CVD). Individuals with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) have higher risk of CVD and display deranged fibrin network structure. Those with maturity onset diabetes of the young (MODY) may also be at increased risk but their fibrin clot properties have not been studied.

METHODS

Plasma clots properties from 13 individuals with HNF1A-MODY, 12 matched-individuals with T2DM and 12 with T1DM were studied using a validated turbidimetric assay and confocal microscopy. Plasma levels of fibrinogen, plasminogen activator inhibitor-1, complement C3 and C-reactive protein were also measured.

RESULTS

MODY clot maximum absorbance was 0.37 ± 0.03 AU, similar to T1DM (0.32 ± 0.03 AU;  = 0.26), but lower than T2DM (0.49 ± 0.03 AU;  = 0.02), with confocal microscopy confirming structural differences. Clot lysis time in MODY was similar to T1DM (456 ± 50 and 402 ± 20 s, respectively;  = 0.09) but shorter than T2DM (588 ± 58 s;  = 0.006). Comparing inflammatory/thrombotic proteins in HNF1A-MODY and T2DM, C3 levels were lower in MODY than T2DM (0.58 ± 0.09 and 0.80 ± 0.1 mg/ml, respectively;  < 0.01).

CONCLUSIONS

HNF1A-MODY fibrin network alterations are at least as pronounced as in T1DM but less thrombotic than T2DM clots. Differences in fibrin clot characteristics comparing HNF1A-MODY and T2DM may, in part, relate to lower C3 levels.

摘要

背景

纤维蛋白网络特征决定了心血管疾病(CVD)的易感性。1 型(T1DM)和 2 型糖尿病(T2DM)患者 CVD 风险较高,且显示纤维蛋白网络结构异常。年轻起病的成人型糖尿病(MODY)患者也可能存在更高的风险,但他们的纤维蛋白凝块特性尚未得到研究。

方法

使用经过验证的比浊法和共聚焦显微镜研究了 13 名 HNF1A-MODY 患者、12 名匹配的 T2DM 患者和 12 名 T1DM 患者的血浆凝块特性。还测量了纤维蛋白原、纤溶酶原激活物抑制剂-1、补体 C3 和 C-反应蛋白的血浆水平。

结果

MODY 组的最大血凝块吸光度为 0.37 ± 0.03 AU,与 T1DM 相似(0.32 ± 0.03 AU;  = 0.26),但低于 T2DM(0.49 ± 0.03 AU;  = 0.02),共聚焦显微镜证实了结构差异。MODY 组的血凝块溶解时间与 T1DM 相似(分别为 456 ± 50 和 402 ± 20 s;  = 0.09),但短于 T2DM(588 ± 58 s;  = 0.006)。比较 HNF1A-MODY 和 T2DM 中的炎症/血栓形成蛋白,MODY 组的 C3 水平低于 T2DM 组(分别为 0.58 ± 0.09 和 0.80 ± 0.1 mg/ml;  < 0.01)。

结论

HNF1A-MODY 纤维蛋白网络的改变至少与 T1DM 一样明显,但血栓形成性不如 T2DM 凝块。与 T2DM 相比,HNF1A-MODY 和 T2DM 之间纤维蛋白凝块特征的差异可能部分与 C3 水平较低有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1d3/7919224/9301366602ce/10.1177_1479164120963048-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1d3/7919224/9301366602ce/10.1177_1479164120963048-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1d3/7919224/9301366602ce/10.1177_1479164120963048-fig1.jpg

相似文献

1
Maturity onset diabetes of the young and fibrin-related thrombosis risk.青年发病型糖尿病与纤维蛋白相关血栓形成风险。
Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120963048. doi: 10.1177/1479164120963048.
2
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.2型糖尿病对冠心病患者纤维蛋白凝块特性的影响。
Thromb Haemost. 2014 Dec;112(6):1142-50. doi: 10.1160/TH14-05-0468. Epub 2014 Sep 4.
3
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.Bβ448位精氨酸突变为赖氨酸的多态性与2型糖尿病患者纤维蛋白凝块结构改变及纤维蛋白溶解有关。
Thromb Haemost. 2017 Jan 26;117(2):295-302. doi: 10.1160/TH16-07-0554. Epub 2016 Dec 8.
4
Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.甲状腺功能障碍与纤维蛋白网络结构:甲状腺功能亢进个体血栓形成风险增加的机制。
J Clin Endocrinol Metab. 2012 May;97(5):1463-73. doi: 10.1210/jc.2011-2894. Epub 2012 Feb 29.
5
Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis.1 型糖尿病患者血浆镁水平降低与纤维蛋白凝块和纤溶的促血栓形成变化有关。
Thromb Haemost. 2020 Feb;120(2):243-252. doi: 10.1055/s-0039-3402808. Epub 2020 Jan 3.
6
Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.与多基因形式的糖尿病相比,肝细胞核因子1A-成熟型糖尿病青年发病型(HNF1A-MODY)和葡萄糖激酶-成熟型糖尿病青年发病型(GCK-MODY)患者的循环胃饥饿素水平更高。
Endocrine. 2015 Dec;50(3):643-9. doi: 10.1007/s12020-015-0627-5. Epub 2015 May 19.
7
Cystatin C is not a good candidate biomarker for HNF1A-MODY.胱抑素 C 不是 HNF1A-MODY 的理想候选生物标志物。
Acta Diabetol. 2013 Oct;50(5):815-20. doi: 10.1007/s00592-012-0378-1. Epub 2012 Feb 19.
8
A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.单剂量达格列净(一种钠-葡萄糖协同转运蛋白2抑制剂)在葡萄糖激酶和肝细胞核因子1α介导的成年发病型糖尿病中诱导的糖尿症高于2型糖尿病。
Endocrine. 2017 Aug;57(2):272-279. doi: 10.1007/s12020-017-1341-2. Epub 2017 Jun 7.
9
Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.青少年起病的成年型糖尿病的临床和实验室线索及与分子诊断的关联。
J Diabetes. 2021 Feb;13(2):154-163. doi: 10.1111/1753-0407.13097. Epub 2020 Oct 2.
10
Altered plasma fibrin clot properties in essential thrombocythemia.原发性血小板增多症患者的血浆纤维蛋白凝块特性改变。
Platelets. 2016;27(2):110-6. doi: 10.3109/09537104.2015.1042967. Epub 2015 May 19.

本文引用的文献

1
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study.糖尿病急性冠脉综合征患者纤溶功能受损预示不良预后:PLATO 亚组研究。
Thromb Haemost. 2020 Mar;120(3):412-422. doi: 10.1055/s-0039-1701011. Epub 2020 Jan 23.
2
Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.纤维蛋白凝块形成与纤维蛋白溶解失衡可预测稳定性冠心病患者的心血管事件。
Thromb Haemost. 2020 Jan;120(1):75-82. doi: 10.1055/s-0039-1700873. Epub 2019 Nov 16.
3
Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.
在一个肝细胞核因子1A-成年发病型糖尿病队列中,磺脲类药物治疗维持成功且糖尿病并发症发生率低。
Diabet Med. 2016 Jul;33(7):976-84. doi: 10.1111/dme.12992. Epub 2015 Nov 17.
4
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.1型糖尿病与心血管疾病:美国心脏协会和美国糖尿病协会的科学声明
Diabetes Care. 2014 Oct;37(10):2843-63. doi: 10.2337/dc14-1720. Epub 2014 Aug 11.
5
Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3.2 型糖尿病中的纤溶不足:炎症途径和补体 C3 的作用。
Diabetologia. 2014 Aug;57(8):1737-41. doi: 10.1007/s00125-014-3267-z. Epub 2014 May 17.
6
Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia.葡萄糖激酶突变伴长期、轻度高血糖患者血管并发症的患病率。
JAMA. 2014 Jan 15;311(3):279-86. doi: 10.1001/jama.2013.283980.
7
Monogenic diabetes: old and new approaches to diagnosis.单基因糖尿病:诊断的新老方法。
Clin Med (Lond). 2013 Jun;13(3):278-81. doi: 10.7861/clinmedicine.13-3-278.
8
Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers.2 型糖尿病中纤维蛋白结构功能的性别特异性改变:与心脏代谢和血管标志物的关系。
J Clin Endocrinol Metab. 2012 Dec;97(12):E2282-7. doi: 10.1210/jc.2012-2128. Epub 2012 Sep 20.
9
Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.甲状腺功能障碍与纤维蛋白网络结构:甲状腺功能亢进个体血栓形成风险增加的机制。
J Clin Endocrinol Metab. 2012 May;97(5):1463-73. doi: 10.1210/jc.2011-2894. Epub 2012 Feb 29.
10
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.补体 C3 是一种具有抗纤维蛋白溶解特性的新型血浆凝块成分。
Diab Vasc Dis Res. 2012 Jul;9(3):216-25. doi: 10.1177/1479164111432788. Epub 2012 Jan 17.